The treatment of rheumatoid arthritis with NF-kappaB inhibitors

Eijiro Jimi, Ichiro Nakamura

Research output: Contribution to journalReview article

Abstract

The nuclear factor kappaB (NF-kappaB) participates in the expression of a wide variety of genes that are involved in the regulation of host immune and inflammatory responses. In rheumatoid arthritis, the activation of NF-kappaB has been detected in synovium and lymphocytes, and induction of arthritis in mice produced strong NF-kappaB transcriptional activity in the affected joints. These evidences suggest that NF-kappaB is an interesting therapeutic target in rheumatoid arthritis. In this review, we are going to review briefly the signaling pathway that leads to NF-kappaB activation and then discuss the possibility that the inhibition of NF-kappaB might provide novel treatment to inhibit bone destruction in rheumatoid arthritis.

Original languageEnglish
Pages (from-to)1627-1632
Number of pages6
JournalNippon rinsho. Japanese journal of clinical medicine
Volume63
Issue number9
Publication statusPublished - Jan 1 2005
Externally publishedYes

Fingerprint

Rheumatoid Arthritis
Synovial Membrane
Arthritis
Joints
Lymphocytes
Bone and Bones
Genes
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

The treatment of rheumatoid arthritis with NF-kappaB inhibitors. / Jimi, Eijiro; Nakamura, Ichiro.

In: Nippon rinsho. Japanese journal of clinical medicine, Vol. 63, No. 9, 01.01.2005, p. 1627-1632.

Research output: Contribution to journalReview article

@article{1610e35350dd4f809daae8c05df0ef6c,
title = "The treatment of rheumatoid arthritis with NF-kappaB inhibitors",
abstract = "The nuclear factor kappaB (NF-kappaB) participates in the expression of a wide variety of genes that are involved in the regulation of host immune and inflammatory responses. In rheumatoid arthritis, the activation of NF-kappaB has been detected in synovium and lymphocytes, and induction of arthritis in mice produced strong NF-kappaB transcriptional activity in the affected joints. These evidences suggest that NF-kappaB is an interesting therapeutic target in rheumatoid arthritis. In this review, we are going to review briefly the signaling pathway that leads to NF-kappaB activation and then discuss the possibility that the inhibition of NF-kappaB might provide novel treatment to inhibit bone destruction in rheumatoid arthritis.",
author = "Eijiro Jimi and Ichiro Nakamura",
year = "2005",
month = "1",
day = "1",
language = "English",
volume = "63",
pages = "1627--1632",
journal = "Astrophysical Journal",
issn = "0004-637X",
publisher = "IOP Publishing Ltd.",
number = "9",

}

TY - JOUR

T1 - The treatment of rheumatoid arthritis with NF-kappaB inhibitors

AU - Jimi, Eijiro

AU - Nakamura, Ichiro

PY - 2005/1/1

Y1 - 2005/1/1

N2 - The nuclear factor kappaB (NF-kappaB) participates in the expression of a wide variety of genes that are involved in the regulation of host immune and inflammatory responses. In rheumatoid arthritis, the activation of NF-kappaB has been detected in synovium and lymphocytes, and induction of arthritis in mice produced strong NF-kappaB transcriptional activity in the affected joints. These evidences suggest that NF-kappaB is an interesting therapeutic target in rheumatoid arthritis. In this review, we are going to review briefly the signaling pathway that leads to NF-kappaB activation and then discuss the possibility that the inhibition of NF-kappaB might provide novel treatment to inhibit bone destruction in rheumatoid arthritis.

AB - The nuclear factor kappaB (NF-kappaB) participates in the expression of a wide variety of genes that are involved in the regulation of host immune and inflammatory responses. In rheumatoid arthritis, the activation of NF-kappaB has been detected in synovium and lymphocytes, and induction of arthritis in mice produced strong NF-kappaB transcriptional activity in the affected joints. These evidences suggest that NF-kappaB is an interesting therapeutic target in rheumatoid arthritis. In this review, we are going to review briefly the signaling pathway that leads to NF-kappaB activation and then discuss the possibility that the inhibition of NF-kappaB might provide novel treatment to inhibit bone destruction in rheumatoid arthritis.

UR - http://www.scopus.com/inward/record.url?scp=26944491895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26944491895&partnerID=8YFLogxK

M3 - Review article

C2 - 16164222

AN - SCOPUS:26944491895

VL - 63

SP - 1627

EP - 1632

JO - Astrophysical Journal

JF - Astrophysical Journal

SN - 0004-637X

IS - 9

ER -